{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:13:01Z","timestamp":1761606781882,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07175"],"award-info":[{"award-number":["19K07175"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012835","name":"Toho University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jchromb.2021.122866","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T04:48:25Z","timestamp":1627361305000},"page":"122866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Separation of vigabatrin enantiomers using mixed-mode chromatography and its application to determine the vigabatrin enantiomer levels in rat plasma"],"prefix":"10.1016","volume":"1179","author":[{"given":"Mayu","family":"Onozato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Uekusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maho","family":"Umino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Ichiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122866_b0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40268-016-0148-6","article-title":"An updated overview on therapeutic drug monitoring of recent antiepileptic drugs","volume":"16","author":"Jacob","year":"2016","journal-title":"Drugs R D"},{"key":"10.1016\/j.jchromb.2021.122866_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.seizure.2006.10.003","article-title":"The pharmacokinetics of vigabatrin in rat blood and cerebrospinal fluid","volume":"16","author":"Tong","year":"2007","journal-title":"Seizure"},{"issue":"Suppl. 1","key":"10.1016\/j.jchromb.2021.122866_b0015","first-page":"23S","article-title":"Effect of food on the absorption of vigabatrin","volume":"27","author":"Frisk-Holmberg","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122866_b0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00007691-199808000-00013","article-title":"A high-performance liquid chromatography micromethod for the simultaneous determination of vigabatrin and gabapentin in serum","volume":"20","author":"Ratnaraj","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2021.122866_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jchromb.2018.01.010","article-title":"RP-HPLC method for simultaneous estimation of vigabatrin, gamma-aminobutyric acid and taurine in biological samples","volume":"1076","author":"Police","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2021.122866_b0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-2999(83)90620-9","article-title":"Anticonvulsant action in mice with sound-induced seizures of the optical isomers of \u03b3-vinyl GABA","volume":"89","author":"Meldrum","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122866_b0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chroma.2008.02.102","article-title":"Liquid chromatographic resolution of vigabatrin and its analogue gamma-amino acids on chiral stationary phases based on (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid","volume":"1188","author":"Lee","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2021.122866_b0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpba.2009.03.030","article-title":"A direct HPLC method for the resolution and quantitation of the R-(-)- and S-(+)-enantiomers of vigabatrin (gamma-vinyl-GABA) in pharmaceutical dosage forms using teicoplanin aglycone chiral stationary phase","volume":"50","author":"Al-Majed","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2021.122866_b0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jchromb.2007.03.042","article-title":"Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection","volume":"854","author":"Franco","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2021.122866_b0050","article-title":"Fluorimetric determination of the enantiomers of vigabatrin, an anti-epileptic drug, by reversed-phase HPLC with a novel diastereomer derivatisation reagent","author":"Uekusa","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2021.122866_b0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpba.2016.05.007","article-title":"Mixed-mode chromatography in pharmaceutical and biopharmaceutical applications","volume":"128","author":"Zhang","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2021.122866_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.trac.2016.05.011","article-title":"Mixed-mode chromatographic stationary phases: Recent advancements and its applications for high-performance liquid chromatography","volume":"82","author":"Zhang","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2021.122866_b0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.trac.2016.04.001","article-title":"Recent advances in materials for stationary phases of mixed-mode high-performance liquid chromatography","volume":"80","author":"Wang","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2021.122866_b0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.talanta.2014.07.060","article-title":"Synthesis of a mixed-model stationary phase derived from glutamine for HPLC separation of structurally different biologically active compounds: HILIC and reversed-phase applications","volume":"131","author":"Aral","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2021.122866_b0075","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.talanta.2015.09.009","article-title":"Preparation, characterization and application of a reversed phase liquid chromatography\/hydrophilic interaction chromatography mixed-mode C18-DTT stationary phase","volume":"146","author":"Wang","year":"2016","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2021.122866_b0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10337-019-03836-4","article-title":"Identification of monomethyl sulfate and sulfate impurities in Zidebactam using LC\u2013MS and application of mixed-mode liquid chromatography with charged aerosol detection and ion chromatography for quantification","volume":"83","author":"Ahirrao","year":"2020","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2021.122866_b0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jchromb.2012.08.020","article-title":"Aqueous normal phase liquid chromatography coupled with tandem time-of-flight quadrupole mass spectrometry for determination of zanamivir in human serum","volume":"906","author":"Ge","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2021.122866_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24244459","article-title":"Simultaneous determination of etomidate and its major metabolite, etomidate acid, in urine using dilute and shoot liquid chromatography-tandem mass spectrometry","volume":"24","author":"Jung","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2021.122866_b0095","unstructured":"H.P. Imtakt: http:\/\/www.imtakt.com\/jp\/Products\/Scherzo\/S@0surface.htm (Accessed on 07 01, 2021)."},{"key":"10.1016\/j.jchromb.2021.122866_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jcph.1309","article-title":"Proposition of a minimal effective dose of vigabatrin for the treatment of infantile spasms using pediatric and adult pharmacokinetic data","volume":"59","author":"Ounissi","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122866_b0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jchromb.2017.10.037","article-title":"Determination of the R(-) and S(+)-enantiomers of vigabatrin in human plasma by ultra-high-performance liquid chromatography and tandem mass-spectrometry","volume":"1070","author":"Duhamel","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2021.122866_b0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0378-4347(00)00327-3","article-title":"Fast isocratic high-performance liquid chromatographic assay method for the simultaneous determination of gabapentin and vigabatrin in human serum","volume":"746","author":"Chollet","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2021.122866_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jchromb.2016.11.016","article-title":"Determination of enantiomeric vigabatrin by derivatization with diacetyl-l-tartaric anhydride followed by ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry","volume":"1040","author":"Zhao","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2021.122866_b0120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.chroma.2007.11.096","article-title":"Fluorescent high-performance liquid chromatographic analysis of vigabatrin enantiomers after derivatizing with naproxen acyl chloride","volume":"1178","author":"Hsieh","year":"2008","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221003470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221003470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:08:52Z","timestamp":1761606532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023221003470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":24,"alternative-id":["S1570023221003470"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122866","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Separation of vigabatrin enantiomers using mixed-mode chromatography and its application to determine the vigabatrin enantiomer levels in rat plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122866"}}